$18.20M Market Cap.
IBIO Market Cap. (MRY)
IBIO Shares Outstanding (MRY)
IBIO Assets (MRY)
Total Assets
$28.73M
Total Liabilities
$7.41M
Total Investments
$1.79M
IBIO Income (MRY)
Revenue
$225.00K
Net Income
-$24.91M
Operating Expense
$16.86M
IBIO Cash Flow (MRY)
CF Operations
-$18.55M
CF Investing
$906.00K
CF Financing
$24.49M
IBIO Dividends (MRY)
Period | Dividends | Yield % | Growth % | Payout Ratio | Coverage Ratio |
|---|---|---|---|---|---|
2024 | $0 | 0% | 0% | 0% | - |
2023 | $0 | 0% | 0% | 0% | - |
2022 | $0 | 0% | 0% | 0% | - |
2021 | $0 | 0% | 0% | 0% | - |
2020 | $0 | 0% | - | 0% | - |
IBIO Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $28,734,000 (-30.27%) | $41,207,000 (-58.55%) | $99,406,000 (-32.36%) | $146,968,000 (56.04%) |
Assets Current | $15,672,000 (-40.32%) | $26,259,000 (-41.74%) | $45,070,000 (-56.91%) | $104,597,000 (69.39%) |
Assets Non-Current | $13,062,000 (-12.62%) | $14,948,000 (-72.49%) | $54,336,000 (28.24%) | $42,371,000 (30.61%) |
Goodwill & Intangible Assets | $5,368,000 (-0.37%) | $5,388,000 (11.07%) | $4,851,000 (409.56%) | $952,000 (-16.78%) |
Shareholders Equity | $21,324,000 (38.64%) | $15,381,000 (-75.77%) | $63,485,000 (-41.53%) | $108,585,000 (91.79%) |
Property Plant & Equipment Net | $6,372,000 (-15.61%) | $7,551,000 (70.03%) | $4,441,000 (-87.22%) | $34,739,000 (11.08%) |
Cash & Equivalents | $14,425,000 (90.33%) | $7,579,000 (-73.57%) | $28,672,000 (-62.96%) | $77,404,000 (40.45%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | -$213,000 (-238.10%) | -$63,000 (-90.91%) |
Deferred Revenue | $200,000 (0%) | $0 (0%) | $100,000 (-76.36%) | $423,000 (-76.63%) |
Total Investments | $1,794,000 (5.16%) | $1,706,000 (-86.33%) | $12,476,000 (-40.94%) | $21,126,000 (0%) |
Investments Current | $713,000 (0%) | $0 (0%) | $10,845,000 (-44.58%) | $19,570,000 (0%) |
Investments Non-Current | $1,081,000 (-36.64%) | $1,706,000 (4.60%) | $1,631,000 (4.82%) | $1,556,000 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $27,000 (-96.62%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $1,000,000 (134.74%) | $426,000 (468.00%) |
Trade & Non-Trade Payables | $358,000 (-80.64%) | $1,849,000 (-56.64%) | $4,264,000 (89.17%) | $2,254,000 (28.14%) |
Accumulated Retained Earnings (Deficit) | -$313,847,000 (-8.62%) | -$288,940,000 (-29.03%) | -$223,930,000 (-28.97%) | -$173,627,000 (-15.43%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $4,824,000 (-72.39%) | $17,475,000 (-32.18%) | $25,766,000 (-21.26%) | $32,722,000 (-0.57%) |
Debt Current | $1,254,000 (-90.89%) | $13,758,000 (-38.17%) | $22,252,000 (2201.14%) | $967,000 (72.06%) |
Debt Non-Current | $3,570,000 (-3.95%) | $3,717,000 (5.78%) | $3,514,000 (-88.93%) | $31,755,000 (-1.83%) |
Total Liabilities | $7,410,000 (-71.31%) | $25,826,000 (-28.10%) | $35,921,000 (-6.46%) | $38,400,000 (2.18%) |
Liabilities Current | $3,840,000 (-82.21%) | $21,582,000 (-29.09%) | $30,436,000 (358.03%) | $6,645,000 (26.91%) |
Liabilities Non-Current | $3,570,000 (-15.88%) | $4,244,000 (-22.63%) | $5,485,000 (-82.73%) | $31,755,000 (-1.83%) |
IBIO Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $225,000 (0%) | $0 (0%) | $1,884,000 (-20.54%) | $2,371,000 (44.75%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $1,462,000 (107.97%) |
Selling General & Administrative Expense | $11,674,000 (-38.61%) | $19,016,000 (-12.59%) | $21,754,000 (-1.26%) | $22,031,000 (93.85%) |
Research & Development Expense | $5,185,000 (-49.79%) | $10,327,000 (5.09%) | $9,827,000 (-1.62%) | $9,989,000 (179.57%) |
Operating Expenses | $16,859,000 (-42.55%) | $29,343,000 (-7.09%) | $31,581,000 (-1.37%) | $32,020,000 (114.35%) |
Interest Expense | $172,000 (107.23%) | $83,000 (0%) | $0 (0%) | $2,454,000 (-0.49%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $9,464,000 (-73.49%) | $35,699,000 (71.70%) | $20,791,000 (0%) | $0 (0%) |
Consolidated Income | -$24,907,000 (61.69%) | -$65,010,000 (-29.01%) | -$50,391,000 (-117.08%) | -$23,213,000 (-41.16%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | -$6,000 (-20.00%) |
Net Income | -$24,907,000 (61.69%) | -$65,010,000 (-29.01%) | -$50,391,000 (-117.14%) | -$23,207,000 (-41.17%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $260,000 (-98.81%) |
Net Income Common Stock | -$24,907,000 (61.69%) | -$65,010,000 (-29.01%) | -$50,391,000 (-114.73%) | -$23,467,000 (38.66%) |
Weighted Average Shares | $3,831,000 (525.72%) | $612,250 (40.41%) | $436,050 (-94.43%) | $7,825,000 (211.53%) |
Weighted Average Shares Diluted | $3,831,000 (525.72%) | $612,250 (40.41%) | $436,050 (-94.43%) | $7,825,000 (211.53%) |
Earning Before Interest & Taxes (EBIT) | -$24,735,000 (61.90%) | -$64,927,000 (-28.85%) | -$50,391,000 (-142.81%) | -$20,753,000 (-48.52%) |
Gross Profit | $225,000 (0%) | $0 (0%) | $1,884,000 (107.26%) | $909,000 (-2.78%) |
Operating Income | -$16,634,000 (43.31%) | -$29,343,000 (1.19%) | -$29,697,000 (4.55%) | -$31,111,000 (-122.17%) |
IBIO Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $906,000 (-87.07%) | $7,009,000 (236.71%) | -$5,127,000 (80.64%) | -$26,478,000 (-2194.45%) |
Net Cash Flow from Financing | $24,494,000 (964.49%) | $2,301,000 (137.57%) | -$6,125,000 (-107.77%) | $78,835,000 (20.93%) |
Net Cash Flow from Operations | -$18,554,000 (39.04%) | -$30,436,000 (18.79%) | -$37,480,000 (-24.67%) | -$30,064,000 (-125.28%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $6,846,000 (132.46%) | -$21,093,000 (56.72%) | -$48,732,000 (-318.61%) | $22,292,000 (-56.02%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | -$692,000 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $10,839,000 (66.68%) | $6,503,000 (132.82%) | -$19,816,000 (0%) |
Capital Expenditure | $906,000 (128.87%) | -$3,138,000 (73.02%) | -$11,630,000 (-125.30%) | -$5,162,000 (-347.31%) |
Issuance (Repayment) of Debt Securities | -$1,138,000 (87.56%) | -$9,147,000 (-48.68%) | -$6,152,000 (-1758.61%) | -$331,000 (77.34%) |
Issuance (Purchase) of Equity Shares | $25,720,000 (124.67%) | $11,448,000 (14767.53%) | $77,000 (-99.91%) | $83,879,000 (21.88%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $33,000 (0%) | $0 (0%) | -$1,000 (50.00%) |
Share Based Compensation | $2,038,000 (-53.59%) | $4,391,000 (0.32%) | $4,377,000 (175.98%) | $1,586,000 (308.76%) |
Depreciation Amortization & Accretion | $1,250,000 (-9.42%) | $1,380,000 (-63.60%) | $3,791,000 (57.04%) | $2,414,000 (7.72%) |
IBIO Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 100.00% | - | 100.00% (161.10%) | 38.30% (-32.92%) |
Profit Margin | -11069.80% | - | -2674.70% (-170.23%) | -989.80% (57.62%) |
EBITDA Margin | -10437.80% | - | -2473.50% (-219.78%) | -773.50% (-8.00%) |
Return on Average Equity (ROAE) | -145.20% (44.18%) | -260.10% (-331.34%) | -60.30% (-157.69%) | -23.40% (91.11%) |
Return on Average Assets (ROAA) | -66.20% (43.52%) | -117.20% (-181.73%) | -41.60% (-144.71%) | -17.00% (76.90%) |
Return on Sales (ROS) | -10993.30% | - | -2674.70% (-205.58%) | -875.30% (-2.60%) |
Return on Invested Capital (ROIC) | -111.30% (39.08%) | -182.70% (-217.74%) | -57.50% (-124.61%) | -25.60% (-10.82%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -0.33 (-182.61%) | -0.12 (89.93%) | -1.14 (90.92%) | -12.58 (-245.78%) |
Price to Sales Ratio (P/S) | 35.93 | - | 30.55 (-75.48%) | 124.59 (46.39%) |
Price to Book Ratio (P/B) | 0.85 (28.08%) | 0.67 (-26.57%) | 0.91 (-70.06%) | 3.03 (-34.73%) |
Debt to Equity Ratio (D/E) | 0.35 (-79.33%) | 1.68 (196.64%) | 0.57 (59.89%) | 0.35 (-46.69%) |
Earnings Per Share (EPS) | -6.5 (93.88%) | -106.2 (8.13%) | -115.6 (-3753.33%) | -3 (80.33%) |
Sales Per Share (SPS) | 0.06 (0%) | 0 (0%) | 4.32 (1326.07%) | 0.3 (-53.53%) |
Free Cash Flow Per Share (FCFPS) | -4.61 (91.60%) | -54.84 (51.31%) | -112.63 (-2401.67%) | -4.5 (22.00%) |
Book Value Per Share (BVPS) | 5.57 (-77.84%) | 25.12 (-82.74%) | 145.59 (949.15%) | 13.88 (-38.44%) |
Tangible Assets Book Value Per Share (TABVPS) | 6.1 (-89.58%) | 58.5 (-73.02%) | 216.84 (1062.08%) | 18.66 (-49.63%) |
Enterprise Value Over EBIT (EV/EBIT) | -1 (0%) | 0 (0%) | -1 (92.31%) | -13 (35.00%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -1.27 (-326.26%) | -0.3 (69.69%) | -0.98 (93.51%) | -15.11 (38.10%) |
Asset Turnover | 0.01 (0%) | 0 (0%) | 0.02 (-5.88%) | 0.02 (-46.88%) |
Current Ratio | 4.08 (235.33%) | 1.22 (-17.83%) | 1.48 (-90.59%) | 15.74 (33.48%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$17,648,000 (47.44%) | -$33,574,000 (31.64%) | -$49,110,000 (-39.41%) | -$35,226,000 (-142.95%) |
Enterprise Value (EV) | $29,721,956 (57.59%) | $18,859,789 (-58.69%) | $45,651,725 (-83.52%) | $277,011,019 (-3.24%) |
Earnings Before Tax (EBT) | -$24,907,000 (61.69%) | -$65,010,000 (-29.01%) | -$50,391,000 (-117.14%) | -$23,207,000 (-41.17%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$23,485,000 (63.04%) | -$63,547,000 (-36.37%) | -$46,600,000 (-154.10%) | -$18,339,000 (-56.32%) |
Invested Capital | $9,925,000 (-58.87%) | $24,133,000 (-60.58%) | $61,213,000 (-35.35%) | $94,689,000 (44.33%) |
Working Capital | $11,832,000 (152.98%) | $4,677,000 (-68.04%) | $14,634,000 (-85.06%) | $97,952,000 (73.33%) |
Tangible Asset Value | $23,366,000 (-34.77%) | $35,819,000 (-62.12%) | $94,555,000 (-35.24%) | $146,016,000 (56.93%) |
Market Capitalization | $18,195,956 (77.58%) | $10,246,789 (-82.21%) | $57,595,725 (-82.49%) | $328,954,019 (25.19%) |
Average Equity | $17,148,250 (-31.38%) | $24,990,250 (-70.07%) | $83,501,500 (-16.67%) | $100,204,750 (589.40%) |
Average Assets | $37,647,000 (-32.15%) | $55,489,250 (-54.23%) | $121,240,750 (-12.20%) | $138,081,250 (165.60%) |
Invested Capital Average | $22,225,250 (-37.47%) | $35,542,000 (-59.42%) | $87,589,500 (8.10%) | $81,030,000 (33.74%) |
Shares | 8,623,676 (926.75%) | 839,901 (92.49%) | 436,331 (-94.99%) | 8,714,014 (84.06%) |
